Document Detail


Three therapeutic tendencies for secondary prevention of myocardial infarction and possible role of Chinese traditional patent medicine: viewpoint of evidence-based medicine.
MedLine Citation:
PMID:  21348994     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objective The possibility of the preventive and therapeutic effects of Chinese traditional patent medicine for myocardial infarction has been reported in the literature, but there have been few studies. This paper presents three tendencies for the secondary prevention of myocardial infarction and presents a systematic evaluation of current research evidence related to the use of Chinese traditional patent medicine in secondary prevention of myocardial infarction, with a goal of making objective recommendations for patient rehabilitation. Method Literature was retrieved from traditional Chinese medicine websites, MEDLINE, CNKI, VIP, CINAHL, The Cochrane Library, EMBASE, HealthSTAR, and Academic ASAP to locate research-based scientific evidence related to the use of Chinese traditional patent medicine for myocardial infarction. Results Some Chinese traditional patent medicine therapies alone or in combination with routine rehabilitation therapies might be useful in patients with myocardial infarction, but we found insufficient evidence to support the use of most Chinese traditional patent medicine therapies in the secondary prevention of myocardial infarction. Conclusion Difficulty in accessing information regarding traditional Chinese medicine has implications for health education in both myocardial infarction and patient safety. Some Chinese traditional patent medicine therapies hold promise for patients in the secondary prevention of myocardial infarction but further research is essential in all areas of traditional Chinese medicine to confirm its efficacy.
Authors:
Hongcai Shang; Jing Chen; Junhua Zhang; Yaozu Xiang; Hongbo Cao; Ming Ren; Hui Wang; Hongjuan Xu; Jing Li; Dan Liu; Jing Hu; Chao Wu; Li Jing; Boli Zhang
Related Documents :
14587644 - The prognostic value of il-8 for cardiac events and restenosis in patients with coronar...
17442204 - Drug-eluting stent for the treatment of small coronary lesion: comparison between sirol...
7828284 - Differential expression of tissue factor protein in directional atherectomy specimens f...
18946894 - Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcati...
10661824 - Risk factors for ascending aortic atheromatosis--a retrospective analysis of 2,263 pati...
15170094 - Progressive nature of paroxysmal atrial fibrillation. observations from a 14-year follo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of evidence-based medicine     Volume:  2     ISSN:  1756-5391     ISO Abbreviation:  J Evid Based Med     Publication Date:  2009 May 
Date Detail:
Created Date:  2011-02-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101497477     Medline TA:  J Evid Based Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  84-91     Citation Subset:  IM    
Copyright Information:
© 2009 Blackwell Publishing Asia Pty Ltd and Chinese Cochrane Center, West China Hospital of Sichuan University.
Affiliation:
Evidence-based Medicine Centre, Tianjin University of Traditional Chinese Medicine, Tianjin, Tianjin, China Postdoctoral Flowing Station of West China Hospital, Sichuan University, Chengdu, Sichuan Province, China Chest Hospital, Tianjin, Tianjin, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Can paying for results help to achieve the Millennium Development Goals? Overview of the effectivene...
Next Document:  Quantitative study on socioeconomic determinants of life expectancy in Beijing, China.